FI903936A0 - Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl. - Google Patents

Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl.

Info

Publication number
FI903936A0
FI903936A0 FI903936A FI903936A FI903936A0 FI 903936 A0 FI903936 A0 FI 903936A0 FI 903936 A FI903936 A FI 903936A FI 903936 A FI903936 A FI 903936A FI 903936 A0 FI903936 A0 FI 903936A0
Authority
FI
Finland
Prior art keywords
och
hypertrofi
hyperplasi
hjaerta
blodkaerl
Prior art date
Application number
FI903936A
Other languages
English (en)
Inventor
Wolfgang Linz
Bernward Schoelkens
Wolfgang Scholz
Gabriele Wiemer
Hansjoerg Urbach
Rainer Henning
Volker Teetz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6386970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI903936(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI903936A0 publication Critical patent/FI903936A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Crucibles And Fluidized-Bed Furnaces (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Element Separation (AREA)
FI903936A 1989-08-11 1990-08-09 Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl. FI903936A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926606A DE3926606A1 (de) 1989-08-11 1989-08-11 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (1)

Publication Number Publication Date
FI903936A0 true FI903936A0 (fi) 1990-08-09

Family

ID=6386970

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903936A FI903936A0 (fi) 1989-08-11 1990-08-09 Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl.

Country Status (22)

Country Link
US (1) US5231083A (fi)
EP (1) EP0417473B1 (fi)
JP (1) JP3452199B2 (fi)
KR (1) KR0185969B1 (fi)
AT (1) ATE94409T1 (fi)
AU (1) AU631914B2 (fi)
CA (1) CA2023089C (fi)
CS (1) CS277644B6 (fi)
DD (1) DD297063A5 (fi)
DE (2) DE3926606A1 (fi)
DK (1) DK0417473T3 (fi)
ES (1) ES2059931T3 (fi)
FI (1) FI903936A0 (fi)
HU (1) HU205008B (fi)
IE (1) IE64604B1 (fi)
IL (1) IL95327A (fi)
NO (1) NO306979B1 (fi)
NZ (1) NZ234836A (fi)
PH (1) PH30831A (fi)
PL (1) PL286442A1 (fi)
PT (1) PT94957B (fi)
ZA (1) ZA906327B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0682947B1 (en) 1994-05-19 1997-09-10 Mitsubishi Chemical Corporation Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
SG68529A1 (en) * 1995-05-25 1999-11-16 Univ Singapore The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
EE05670B1 (et) * 1999-08-30 2013-08-15 Aventis Pharma Deutschland Gmbh Ramipriil kardiovaskulaarsete haigusjuhtude „rahoidmiseks
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
JP2008519062A (ja) * 2004-11-05 2008-06-05 キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド 個々に被覆された安定化ラミプリル粒子、組成物及び方法
US8980924B2 (en) 2010-11-24 2015-03-17 The Trustees Of Columbia University In The City Of New York Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
US9637450B2 (en) 2013-03-14 2017-05-02 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
EP3495357B1 (en) 2013-03-14 2021-05-05 The Trustees of Columbia University in the City of New York 4-phenylpiperidines, their preparation and use
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
KR102429220B1 (ko) 2014-04-30 2022-08-04 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 치환 4-페닐피페리딘, 그 제조 및 사용

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4311705A (en) * 1980-10-06 1982-01-19 E. R. Squibb & Sons, Inc. Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4602002A (en) * 1983-02-07 1986-07-22 Merck & Co., Inc. N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
US4548941A (en) * 1984-07-30 1985-10-22 Merck & Co., Inc. 1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers
US4587253A (en) * 1984-07-30 1986-05-06 Merck & Co., Inc. Bridged pyridine compounds useful as calcium channel blockers and analgesics
US4599341A (en) * 1984-10-01 1986-07-08 Merck & Co., Inc. Substituted and bridged pyridines useful as calcium channel blockers
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
DE3705220A1 (de) * 1987-02-19 1988-09-01 Boehringer Ingelheim Kg Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Also Published As

Publication number Publication date
US5231083A (en) 1993-07-27
JP3452199B2 (ja) 2003-09-29
AU6092090A (en) 1991-02-14
DE3926606A1 (de) 1991-02-14
CA2023089A1 (en) 1991-02-12
NO903532L (no) 1991-02-12
IL95327A0 (en) 1991-06-30
DK0417473T3 (da) 1993-12-13
EP0417473A1 (de) 1991-03-20
ZA906327B (en) 1991-05-29
KR0185969B1 (ko) 1999-05-01
CS395890A3 (en) 1992-08-12
NZ234836A (en) 1997-05-26
PL286442A1 (en) 1992-03-09
ATE94409T1 (de) 1993-10-15
IL95327A (en) 1995-10-31
PT94957B (pt) 1997-05-28
NO306979B1 (no) 2000-01-24
DE59002721D1 (de) 1993-10-21
PT94957A (pt) 1991-05-22
KR910004189A (ko) 1991-03-28
IE902910A1 (en) 1991-02-27
JPH0383957A (ja) 1991-04-09
CA2023089C (en) 2003-01-14
HUT54504A (en) 1991-03-28
AU631914B2 (en) 1992-12-10
NO903532D0 (no) 1990-08-10
CS277644B6 (en) 1993-03-17
EP0417473B1 (de) 1993-09-15
ES2059931T3 (es) 1994-11-16
PH30831A (en) 1997-10-17
HU205008B (en) 1992-03-30
DD297063A5 (de) 1992-01-02
HU904966D0 (en) 1991-01-28
IE64604B1 (en) 1995-08-23

Similar Documents

Publication Publication Date Title
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
DK51986A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
SE8503680D0 (sv) Indolderivat
BR9205811A (pt) Derivados heterociclicos de aminas ciclicas
FI903936A0 (fi) Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl.
ES2059301T3 (es) Utilizacion de inhibidores de la enzima convertidora de angiotensina para el tratamiento de la aterosclerosis, trombosis y de la enfermedad vascular periferica.
NO165921C (no) Fremgangsmaate for fremstilling av disubstituerte prolinderivater.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
BG96171A (bg) Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат
MX9400253A (es) Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
ES541780A0 (es) Tetrahidrotienopiridinas
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ES2040750T3 (es) Un procedimiento para la preparacion de un derivado de isoquinolinol.
NO880405D0 (no) Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner.
FI944967A (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
ECSP951499A (es) Compuestos ariltios
DK572189A (da) Substituerede adeninderivater og farmaceutisk praeparat indeholdende dem

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT